Morgan Stanley’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-213,234
Closed -$35.2M 8278
2021
Q2
$35.2M Sell
213,234
-344,541
-62% -$56.9M ﹤0.01% 1592
2021
Q1
$85.5M Buy
557,775
+302,449
+118% +$46.4M 0.01% 848
2020
Q4
$32M Sell
255,326
-239,005
-48% -$30M ﹤0.01% 1422
2020
Q3
$50.1M Buy
494,331
+411,270
+495% +$41.7M 0.01% 897
2020
Q2
$8.08M Buy
83,061
+1,277
+2% +$124K ﹤0.01% 2167
2020
Q1
$6.79M Sell
81,784
-19,513
-19% -$1.62M ﹤0.01% 2150
2019
Q4
$11.3M Buy
101,297
+22,726
+29% +$2.53M ﹤0.01% 2300
2019
Q3
$7.8M Sell
78,571
-119,818
-60% -$11.9M ﹤0.01% 2382
2019
Q2
$19.7M Sell
198,389
-141,419
-42% -$14M 0.01% 1501
2019
Q1
$37.5M Buy
339,808
+91,947
+37% +$10.1M 0.01% 1005
2018
Q4
$22.8M Sell
247,861
-216,036
-47% -$19.9M 0.01% 1356
2018
Q3
$51.1M Buy
463,897
+140,675
+44% +$15.5M 0.01% 947
2018
Q2
$30.2M Sell
323,222
-75,018
-19% -$7M 0.01% 1257
2018
Q1
$33M Buy
398,240
+62,426
+19% +$5.18M 0.01% 1224
2017
Q4
$30.6M Buy
335,814
+165,103
+97% +$15M 0.01% 1319
2017
Q3
$13M Buy
170,711
+47,190
+38% +$3.59M ﹤0.01% 2018
2017
Q2
$9.26M Buy
123,521
+63,978
+107% +$4.8M ﹤0.01% 2248
2017
Q1
$3.88M Sell
59,543
-742,086
-93% -$48.4M ﹤0.01% 3132
2016
Q4
$44.2M Buy
801,629
+679,537
+557% +$37.5M 0.01% 965
2016
Q3
$6.9M Sell
122,092
-340,488
-74% -$19.2M ﹤0.01% 2354
2016
Q2
$19.3M Buy
462,580
+411,824
+811% +$17.2M 0.01% 1452
2016
Q1
$2.17M Buy
50,756
+26,569
+110% +$1.14M ﹤0.01% 3284
2015
Q4
$1.1M Sell
24,187
-22,865
-49% -$1.04M ﹤0.01% 3984
2015
Q3
$1.83M Sell
47,052
-49,285
-51% -$1.91M ﹤0.01% 3596
2015
Q2
$3.5M Sell
96,337
-68,261
-41% -$2.48M ﹤0.01% 3122
2015
Q1
$4.75M Buy
164,598
+37,640
+30% +$1.09M ﹤0.01% 2806
2014
Q4
$3.08M Buy
+126,958
New +$3.08M ﹤0.01% 3184